India Entering Era of Personalised and Precision Medicine Driven by Genomics, AI, and Biotechnology: Dr. Jitendra Singh

**Executive Summary** This document outlines India's entry into the era of personalized and precision medicine driven by genomics, AI, and biotechnology, as stated by Union Minister Dr. Jitendra Singh. It highlights India's strengths in genetic research, its emerging role as a global healthcare destination, and policies aimed at positioning the country as a leader in biomanufacturing. Key initiatives and policy changes are detailed, emphasizing accelerated innovation and private sector participation in advanced technologies. **Key Points / Main Content** * **India's Transformative Healthcare Era:** * India is entering a new phase of personalized and precision medicine powered by genomics, artificial intelligence, and advanced biotechnology. * This will enable early disease detection and targeted treatments before symptoms manifest. * **Genomic Research and Initiatives:** * India possesses a significant genetic diversity and expanding genomic databases, fostering opportunities for predictive healthcare, diagnostics, and tailored treatments. * The Genome India initiative has already sequenced 10,000 genomes, with a goal to sequence one million genomes for enhanced preventive healthcare and disease prediction. * India has a unique advantage in genomic research due to its large genetic pool and numerous distinct communities. * **Biotechnology and Biomanufacturing:** * The Bio-E3 Policy (Biotechnology for Economy, Employment and Environment) aims to accelerate innovation in biomanufacturing and elevate India's global standing. * India is already a major bio-manufacturing hub, ranking third in the Asia-Pacific region, supported by initiatives like bio-foundries and incubators. * Biotechnology is anticipated to drive the next industrial revolution, similar to information technology's past impact. * **Advancements in Vaccines and Therapies:** * India has developed the world's first DNA vaccine for COVID-19 and an indigenous HPV vaccine for cervical cancer prevention. * Successful gene-therapy based treatment trials for hemophilia and ongoing research in other genetic diseases demonstrate cutting-edge breakthroughs. * **AI-Enabled Diagnostics and Healthcare:** * AI-enabled diagnostics are crucial for improving early disease detection, such as in breast cancer. * Large-scale screening using AI-based thermal imaging technologies can extend diagnostic services to remote areas via mobile health units. * Early detection is transforming cancer outcomes, making some cancers curable in early stages. * **Emerging Scientific Research Areas:** * India is collaborating on space-medicine initiatives to study biological responses in microgravity and their healthcare implications. * **Nuclear Sector Reforms:** * The recently introduced SHANTI Act allows private participation in India's nuclear sector for the first time. * This reform is expected to boost investments in small modular reactors, nuclear technologies, and nuclear medicine research, potentially leading to breakthroughs in treating diseases like acute lymphoid leukemia and fatty liver disease. * The reform will create opportunities for start-ups and smaller companies in emerging nuclear technologies. * **Research, Development, and Innovation Fund:** * A ₹1 lakh crore Research, Development, and Innovation (RDI) Fund has been established to encourage private sector participation in advanced technologies like biotechnology and nuclear science. * **Global Recognition and Collaboration:** * India is recognized globally as a cost-effective and high-quality healthcare destination, supported by scientific research and health data systems. * There is growing global interest in collaborating with India in life sciences and biotechnology. **Impact Analysis** **Patients** * **Impact:** Patients will benefit from earlier disease detection, more personalized and precise treatments tailored to their genetic profile, lifestyle, and environmental factors, potentially leading to improved health outcomes and cure rates for certain diseases. * **Action Required:** Patients will likely need to engage with healthcare providers who utilize these advanced diagnostic and treatment technologies. **Healthcare Providers and Medical Professionals** * **Impact:** Healthcare providers will gain access to advanced diagnostic tools and therapeutic approaches powered by genomics, AI, and biotechnology, enabling more effective patient care. * **Action Required:** Medical professionals will need to upskill and adapt to incorporating these new technologies and personalized treatment protocols into their practice. **Research Institutions and Scientists** * **Impact:** Research institutions and scientists will benefit from increased opportunities for funding, collaboration, and access to advanced technologies, fostering innovation in genomics, biotechnology, and nuclear medicine. * **Action Required:** Researchers should leverage the RDI Fund and participate in collaborative initiatives to advance scientific discovery and technological development. **Biotechnology and Pharmaceutical Companies** * **Impact:** Companies will find an accelerated environment for innovation in biomanufacturing and biotechnology, with opportunities for growth driven by supportive policies and a strong domestic market. The opening of the nuclear sector also presents new avenues for nuclear medicine research and development. * **Action Required:** Companies should actively engage with initiatives like the Bio-E3 Policy, explore opportunities in bio-foundries and incubators, and consider participating in the RDI Fund and the newly opened nuclear sector. **Start-ups and Entrepreneurs** * **Impact:** Start-ups and entrepreneurs will have enhanced opportunities to participate in emerging technological sectors, including biotechnology, biomanufacturing, and nuclear technologies, supported by incubators and new funding mechanisms. * **Action Required:** Entrepreneurs should explore relevant incubators, seek funding from the RDI Fund, and identify niches within the advanced technology sectors being promoted. **Government and Policy Makers** * **Impact:** The government will see progress towards its goals of positioning India as a global leader in healthcare and biotechnology, with the implementation of new policies and funds expected to drive economic growth and improve public health. * **Action Required:** Continue to implement and refine policies, monitor progress of initiatives, and foster a conducive environment for research and development and private sector investment.

Key Entities Referenced